TCL Archive Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes February 5, 1982
TCL Archive RTOG Finds Twice A Day Radiation For Advanced Head And Neck Cancer Improved Local Tumor Control Rate August 25, 2000
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products. July 9, 2004
